gray retatrutide – new weight loss medication in development Retatrutide 10mg & 20mg Research
Description
ActRII: activin type II receptors, T2D: type 2 diabetes, 6 MWD: 6-minute walk distance, GLP-1/GIP: glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide, SARMs: selective androgen receptor modulators, DMD: Duchenne muscular dystrophy, GLP-1RAs: GLP-1 receptor agonists, IGF-1: insulin-like growth factor, CV: cardiovascular Conclusions Skeletal muscle wasting is a frequent and clinically significant complication in patients with T2D and obesity, which is exacerbated by chronic inflammation, insulin resistance and metabolic dysregulation
2025 Feb 5;14(1):18
to what should I actually be eating
REVIEW ARTCLE View the full PDF of the white paper
No preservatives, no guessworkjust ingredients that gently support hydration and restore balance
